NCT03227081

Brief Summary

The purpose of the study is to examine whether sleep affects the development of intrusive memories.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 17, 2017

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

July 20, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 24, 2017

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 4, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 4, 2020

Completed
Last Updated

March 10, 2022

Status Verified

March 1, 2022

Enrollment Period

2.6 years

First QC Date

July 20, 2017

Last Update Submit

March 9, 2022

Conditions

Intrusive Memories

Outcome Measures

Primary Outcomes (1)

  • Intrusive memories

    Intrusive memories measured with an intrusion diary

    seven consecutive days

Study Arms (2)

Sleep

NO INTERVENTION

Sleep

Sleep Deprivation

EXPERIMENTAL

Sleep Deprivation

Behavioral: Sleep Deprivation

Interventions

Sleep DeprivationBEHAVIORAL

Sleep Deprivation

Sleep Deprivation

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • healthy participants
  • German on a native level

You may not qualify if:

  • former or present psychiatric disorders
  • physical illnesses
  • history of trauma
  • pregnancy or lactation period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr. Dimitris Repantis

Berlin, Germany

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. med.

Study Record Dates

First Submitted

July 20, 2017

First Posted

July 24, 2017

Study Start

July 17, 2017

Primary Completion

February 4, 2020

Study Completion

February 4, 2020

Last Updated

March 10, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations

DE(1)